Accent MRI Pacemaker and Tendril MRI Lead New Technology Assessment
1 other identifier
observational
78
1 country
1
Brief Summary
The intent of this study is to evaluate the performance of the implanted Accent MRI TM system in a clinical setting and optionally in the MRI environment. This system includes the St. Jude Medical Tendril MRI™ lead and SJM Accent MRITM DR pacemaker. Also the MRI Activator™ will be evaluated in this study. The MRI Activator is a handheld device that allows the user to enable and disable MRI Settings as well as check the status of MRI Settings in the pacemaker. The patient population under study includes patients with a standard bradycardia pacing indication.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2011
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 9, 2010
CompletedFirst Posted
Study publicly available on registry
December 10, 2010
CompletedStudy Start
First participant enrolled
February 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2011
CompletedFebruary 4, 2019
February 1, 2019
9 months
December 9, 2010
February 1, 2019
Conditions
Study Arms (1)
Accent MRI Group
Interventions
Eligibility Criteria
Patients with approved Class I or Class II indication per ESC guidelines for implantation of a dual chamber pacemaker or single chamber pacemaker.
You may qualify if:
- Approved Class I or Class II indication per ESC guidelines for implantation of a dual chamber pacemaker or single chamber pacemaker.
- Receiving a new Accent MRITM pacemaker and Tendril MRI™ lead (either initial implant or complete system change out with no abandoned devices).
- Ability to provide informed consent for study participation.
- Is willing and able to comply with the prescribed follow-up tests and schedule of evaluations.
You may not qualify if:
- Have an existing pacemaker or ICD (abandoned devices and/or leads are not allowed. A new pacemaker and lead or complete system change out is required for enrollment).
- Have an existing active/inactive implanted medical device (e. g., Neurostimulator, infusion pump, etc.).
- Have a non-MRI compatible device or material implant (e.g., intracranial aneurysm clip, non-MRI compatible devices or material, metals or alloys, etc.).
- Have a lead extender or adaptor.
- Have a mechanical, prosthetic or bioprosthetic tricuspid heart valve.
- Have an abdominal diameter (approximately \> 60cm) which results in contact with the magnet façade.
- Are currently participating in a study that includes an active treatment arm.
- Are pregnant or planning to become pregnant during the duration of the study.
- Have a life expectancy of less than 6 months due to any condition.
- Are less than 18 years of age.
- Are unable to comply with the follow up schedule.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Unknown Facility
Graz, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 9, 2010
First Posted
December 10, 2010
Study Start
February 1, 2011
Primary Completion
November 1, 2011
Study Completion
November 1, 2011
Last Updated
February 4, 2019
Record last verified: 2019-02